Medicine shortages in southern Africa, particularly of anti-retrovirals for HIV patients, require urgent attention. A regional approach to distribution has been tried in South America and could work for the region.
Articles on Antiviral drugs
Displaying 41 - 49 of 49 articles
Scientists around the world are trying to develop effective treatments for Ebola infection. But a process of viral mutation, known as “genetic drift”, could potentially compromise their efforts.
Ever since combination antiretroviral therapy (ART) was introduced in 1996, HIV has been transformed from a fatal diagnosis to a chronic and manageable condition for many people. ART made it possible for…
One of the greatest success stories in modern medicine is that HIV is no longer a death sentence, but a chronic, manageable disease that often can be managed with a single tablet a day. Antiretroviral…
A new oral antiviral drug may be a future tool in the global fight against measles, according to a new international study. The research, published today in the journal Science Translational Medicine…
Antiviral drugs are largely ineffective for reducing hospital admissions and complications from influenza, and come with serious side-effects, according to a research review published by the Cochrane Collaboration…
Hepatitis C is a hidden epidemic affecting 170 million people worldwide. Hepatitis C kills nearly 700 Australians every year, mostly from chronic liver failure and liver cancer, and costs over $78.9 million…
Hepatitis C is a blood borne virus and a major cause of liver disease and liver cancer. Around 150m people globally are estimated to suffer from the virus and in the UK, and many developed countries, people…
A new antiviral drug has effectively prevented the spread of influenza in laboratory models. It works by blocking the viruses…
Top contributors
-
Professor and Director of Quantitative Biosciences Institute & Senior Investigator at the Gladstone Institutes, University of California, San Francisco
-
Professor of Pharmaceutical Chemistry, Macquarie University
-
Deputy Director, WHO Collaborating Centre for Reference and Research on Influenza
-
Infectious Diseases Physician, St Vincent's Hospital, Sydney; Scientia Professor, Kirby Institute, UNSW
-
Assistant Professor of Infectious Diseases, University of Virginia
-
Virology Research Scientist, University of Washington
-
Melbourne Laureate Professor, University of Melbourne; Director, The Peter Doherty Institute for Infection and Immunity
-
Research associate, The Kirby Institute, UNSW
-
Biologiste, chargée de recherche au CNRS, École normale supérieure (ENS) – PSL
-
Dean and Hunterdon Professor of Public Health & Health Equity, School of Public Health, Rutgers University
-
Honorary Professor Faculty of Health and Medical Science, Univeristy of Sydney; Senior Researcher Sydney Institue for Infectious Disease, University of Sydney., University of Sydney
-
Professor in Public Health and Epidemiology, University of Bristol
-
Deputy Director, Burnet Institute, Adjunct Professor, Monash University, Burnet Institute
-
Doctoral Student in Biochemistry, University of Washington
-
Professor in Microbiology and Molecular Biology, UNSW